These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 22968823)
1. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections. Lee SJ; Rim TH; Jang SY; Kim CY; Shin DY; Lee EJ; Lee SY; Yoon JS Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):261-70. PubMed ID: 22968823 [TBL] [Abstract][Full Text] [Related]
2. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy. Xu D; Liu Y; Xu H; Li H Can J Ophthalmol; 2012 Feb; 47(1):34-41. PubMed ID: 22333849 [TBL] [Abstract][Full Text] [Related]
3. Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series. Chee E; Chee SP Eye (Lond); 2008 Feb; 22(2):311-5. PubMed ID: 17917686 [TBL] [Abstract][Full Text] [Related]
4. Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease. Lee JM; Lee H; Park M; Baek S J Craniofac Surg; 2012 Nov; 23(6):1755-8. PubMed ID: 23147303 [TBL] [Abstract][Full Text] [Related]
5. [Triamcinolone acetonide deep fornix injection for the treatment of upper eyelid retraction in patients with thyroid-associated ophthalmopathy]. Luo LH; Gao LX; Wang W; Miao H; Ma XM; Li DM Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):524-529. PubMed ID: 32842335 [No Abstract] [Full Text] [Related]
7. Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy. Li D; Sun F Biomed Res Int; 2021; 2021():9514279. PubMed ID: 33791385 [TBL] [Abstract][Full Text] [Related]
9. Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis. Sohn EH; Wang R; Read R; Roufas A; Teo L; Moorthy R; Albini T; Vasconcelos-Santos DV; Dustin LD; Zamir E; Chee SP; McCluskey P; Smith R; Rao N Ophthalmology; 2011 Oct; 118(10):1932-7. PubMed ID: 21708408 [TBL] [Abstract][Full Text] [Related]
10. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
11. Intraocular Pressure Increases After Intraarticular Knee Injection With Triamcinolone but Not Hyaluronic Acid. Taliaferro K; Crawford A; Jabara J; Lynch J; Jung E; Zvirbulis R; Banka T Clin Orthop Relat Res; 2018 Jul; 476(7):1420-1425. PubMed ID: 29533245 [TBL] [Abstract][Full Text] [Related]
12. Transconjunctival Triamcinolone Injection for Upper Lid Retraction in Thyroid Eye Disease-A New Injection Method. Young SM; Kim YD; Lang SS; Woo KI Ophthalmic Plast Reconstr Surg; 2018; 34(6):587-593. PubMed ID: 29672347 [TBL] [Abstract][Full Text] [Related]
13. Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves' ophthalmopathy. Bordaberry M; Marques DL; Pereira-Lima JC; Marcon IM; Schmid H Acta Ophthalmol; 2009 Feb; 87(1):58-64. PubMed ID: 18937809 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Sutter FK; Simpson JM; Gillies MC Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370 [TBL] [Abstract][Full Text] [Related]
16. [Safety and efficacy of subconjunctival triamcinolone injections in the management of uveitic macular edema: retrospective study of thirty-one cases]. Bleriot A; Couret C; Le Meur G; Lebranchu P; Weber M J Fr Ophtalmol; 2014 Oct; 37(8):599-604. PubMed ID: 25199486 [TBL] [Abstract][Full Text] [Related]
17. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Challa JK; Gillies MC; Penfold PL; Gyory JF; Hunyor AB; Billson FA Aust N Z J Ophthalmol; 1998 Nov; 26(4):277-81. PubMed ID: 9843254 [TBL] [Abstract][Full Text] [Related]
18. Triamcinolone acetonide injection in the treatment of upper eyelid retraction in Graves' ophthalmopathy evaluated by 3.0 Tesla magnetic resonance imaging. Duan M; Xu DD; Zhou HL; Fang HY; Meng W; Wang YN; Jin ZY; Chen Y; Zhang ZH Indian J Ophthalmol; 2022 May; 70(5):1736-1741. PubMed ID: 35502063 [TBL] [Abstract][Full Text] [Related]
19. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075 [TBL] [Abstract][Full Text] [Related]
20. [The efficacy and safety of subconjunctival triamcinolone acetonide injections in treatment of uveitic macular edema]. Liu X; Wang M; Zhao C; Gao F; Zhang M Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):734-8. PubMed ID: 26693767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]